Clinical trials continue to shape metastatic breast cancer treatment, making therapies safer, more tolerable, and more ...

Immunocore (IMCR) announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous ...

The choice of drugs for patients with status epilepticus that is refractory to treatment with benzodiazepines has not been thoroughly studied. In a randomized, blinded, adaptive trial, we compared the ...

Please provide your email address to receive an email when new articles are posted on . Second-line tisagenlecleucel conferred identical EFS as standard treatment for relapsed or refractory aggressive ...

Patients diagnosed with major depressive disorder (MDD) are defined as having TRD if they have failed two or more antidepressant therapies. MDD is a serious condition characterized by depressed mood ...

Associate Professor of Public Policy, University of Maryland, Baltimore County A commonly used malaria drug was recently proposed as a treatment for COVID-19 during a White House press briefing, even ...

Patients with infective endocarditis on the left side of the heart are typically treated with intravenous antibiotic agents for up to 6 weeks. Whether a shift from intravenous to oral antibiotics once ...

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 18 June 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company ...